{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:10:18Z","timestamp":1791159018558,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Class B scavenger receptors (SR-Bs), such as SR-BI\/II or CD36, bind lipoproteins but also mediate bacterial recognition and phagocytosis. In evaluating whether blocking receptors can prevent intracellular bacterial proliferation, phagocyte cytotoxicity, and proinflammatory signaling in bacterial infection\/sepsis, we found that SR-BI\/II\u2013 or CD36-deficient phagocytes are characterized by a reduced intracellular bacterial survival and a lower cytokine response and were protected from bacterial cytotoxicity in the presence of antibiotics. Mice deficient in either SR-BI\/II or CD36 are protected from antibiotic-treated cecal ligation and puncture (CLP)-induced sepsis, with greatly increased peritoneal granulocytic phagocyte survival (8-fold), a drastic diminution in peritoneal bacteria counts, and a 50\u201370% reduction in systemic inflammation (serum levels of IL-6, TNF-\u03b1, and IL-10) and organ damage relative to CLP in wild-type mice. The survival rate of CD36-deficient mice after CLP was 58% compared with 17% in control mice. When compensated for mineralocorticoid and glucocorticoid deficiency, SR-BI\/II\u2013deficient mice had nearly a 50% survival rate versus 5% in mineralo-\/glucocorticoid-treated controls. Targeting SR-B receptors with L-37pA, a peptide that functions as an antagonist of SR-BI\/II and CD36 receptors, also increased peritoneal granulocyte counts, as well as reduced peritoneal bacteria and bacterium-induced cytokine secretion. In the CLP mouse sepsis model, L-37pA improved survival from 6 to 27%, reduced multiple organ damage, and improved kidney function. These results demonstrate that the reduction of both SR-BI\/II\u2013 and CD36-dependent bacterial invasion and inflammatory response in the presence of antibiotic treatment results in granulocyte survival and local bacterial containment, as well as reduces systemic inflammation and organ damage and improves animal survival during severe infections.<\/jats:p>","DOI":"10.4049\/jimmunol.1003445","type":"journal-article","created":{"date-parts":[[2012,2,11]],"date-time":"2012-02-11T19:33:25Z","timestamp":1328988805000},"page":"2749-2758","source":"Crossref","is-referenced-by-count":56,"title":["Class B Scavenger Receptor Types I and II and CD36 Targeting Improves Sepsis Survival and Acute Outcomes in Mice"],"prefix":"10.1093","volume":"188","author":[{"given":"Asada","family":"Leelahavanichkul","sequence":"first","affiliation":[{"name":"Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892"},{"name":"Department of Microbiology, Faculty of Medicine, Chulalongkorn University , Bangkok ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V","family":"Bocharov","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Kurlander","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina N","family":"Baranova","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana G","family":"Vishnyakova","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C P","family":"Souza","sequence":"additional","affiliation":[{"name":"Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhen","family":"Hu","sequence":"additional","affiliation":[{"name":"Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Doi","sequence":"additional","affiliation":[{"name":"Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Vaisman","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Amar","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Sviridov","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T","family":"Remaley","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Csako","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy P","family":"Patterson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health , Bethesda, MD 20892"},{"name":"Office of Biotechnology Activities, Office of the Director, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S T","family":"Yuen","sequence":"additional","affiliation":[{"name":"Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Star","sequence":"additional","affiliation":[{"name":"Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Eggerman","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health , Bethesda, MD 20892"},{"name":"Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,15]]},"reference":[{"key":"2025032409590723700_r1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jama.298.4.456","article-title":"Caring for the critically ill patient: challenges and opportunities","volume":"298","author":"Angus","year":"2007","journal-title":"JAMA"},{"key":"2025032409590723700_r2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit. Care Med."},{"key":"2025032409590723700_r3","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"2025032409590723700_r4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.ccx.0000139363.76068.7b","article-title":"Management of severe sepsis and septic shock","volume":"10","author":"Sessler","year":"2004","journal-title":"Curr. Opin. Crit. Care"},{"key":"2025032409590723700_r5","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1097\/CCM.0b013e3181b0266c","article-title":"Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial","volume":"37","author":"Dellinger","year":"2009","journal-title":"Crit. Care Med."},{"key":"2025032409590723700_r6","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMra043632","article-title":"Management of sepsis","volume":"355","author":"Russell","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"2025032409590723700_r7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1568010043483962","article-title":"Modulation of innate immune responses in the treatment of sepsis and pneumonia","volume":"3","author":"Schultz","year":"2004","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"2025032409590723700_r8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"2025032409590723700_r9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.178.2.993","article-title":"Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo","volume":"178","author":"Knapp","year":"2007","journal-title":"J. Immunol."},{"key":"2025032409590723700_r10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1084\/jem.20080162","article-title":"Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis","volume":"205","author":"Plitas","year":"2008","journal-title":"J. Exp. Med."},{"key":"2025032409590723700_r11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SHK.0b013e318157ee55","article-title":"Role of Toll-like receptors in the development of sepsis","volume":"29","author":"Tsujimoto","year":"2008","journal-title":"Shock"},{"key":"2025032409590723700_r12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1160\/TH09-05-0323","article-title":"Role of Toll-like receptors, NOD-like receptors and RIG-I-like receptors in endothelial cells and systemic infections","volume":"102","author":"Opitz","year":"2009","journal-title":"Thromb. Haemost."},{"key":"2025032409590723700_r13","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1128\/IAI.00727-09","article-title":"Uncoupling scavenger receptor A-mediated phagocytosis of bacteria from endotoxic shock resistance","volume":"77","author":"Amiel","year":"2009","journal-title":"Infect. Immun."},{"key":"2025032409590723700_r14","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1073\/pnas.91.5.1863","article-title":"The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid","volume":"91","author":"Dunne","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032409590723700_r15","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1128\/IAI.70.10.5346-5354.2002","article-title":"The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses","volume":"70","author":"Peiser","year":"2002","journal-title":"Infect. Immun."},{"key":"2025032409590723700_r16","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1128\/IAI.00124-06","article-title":"Identification of Neisseria meningitidis nonlipopolysaccharide ligands for class A macrophage scavenger receptor by using a novel assay","volume":"74","author":"Peiser","year":"2006","journal-title":"Infect. Immun."},{"key":"2025032409590723700_r17","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.4049\/jimmunol.181.10.7147","article-title":"Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling","volume":"181","author":"Baranova","year":"2008","journal-title":"J. Immunol."},{"key":"2025032409590723700_r18","doi-asserted-by":"crossref","first-page":"36072","DOI":"10.1074\/jbc.M314264200","article-title":"Targeting of scavenger receptor class B type I by synthetic amphipathic alpha-helical-containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells","volume":"279","author":"Bocharov","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2025032409590723700_r19","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1126\/science.1116006","article-title":"Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection","volume":"309","author":"Philips","year":"2005","journal-title":"Science"},{"key":"2025032409590723700_r20","doi-asserted-by":"crossref","first-page":"22771","DOI":"10.1074\/jbc.M211032200","article-title":"Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1","volume":"278","author":"Vishnyakova","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2025032409590723700_r21","doi-asserted-by":"crossref","first-page":"16888","DOI":"10.1073\/pnas.0602126103","article-title":"CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells","volume":"103","author":"Vishnyakova","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032409590723700_r22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"2025032409590723700_r23","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1074\/jbc.M405009200","article-title":"Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1\/2 and p38 mitogen-activated protein kinases","volume":"280","author":"Baranova","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2025032409590723700_r24","doi-asserted-by":"crossref","first-page":"47373","DOI":"10.1074\/jbc.M208788200","article-title":"A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid","volume":"277","author":"Moore","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2025032409590723700_r25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2006.06.007","article-title":"A CD36-dependent signaling cascade is necessary for macrophage foam cell formation","volume":"4","author":"Rahaman","year":"2006","journal-title":"Cell Metab."},{"key":"2025032409590723700_r26","doi-asserted-by":"crossref","first-page":"18897","DOI":"10.1074\/jbc.M002411200","article-title":"Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic alpha-helix as a recognition motif","volume":"275","author":"Williams","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2025032409590723700_r27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.ki.5000165","article-title":"Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis","volume":"69","author":"Dear","year":"2006","journal-title":"Kidney Int."},{"key":"2025032409590723700_r28","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1046\/j.1523-1755.2003.00268.x","article-title":"Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice","volume":"64","author":"Miyaji","year":"2003","journal-title":"Kidney Int."},{"key":"2025032409590723700_r29","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ki.2008.97","article-title":"AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality","volume":"73","author":"Doi","year":"2008","journal-title":"Kidney Int."},{"key":"2025032409590723700_r30","doi-asserted-by":"crossref","first-page":"F1825","DOI":"10.1152\/ajprenal.90442.2008","article-title":"Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice","volume":"295","author":"Leelahavanichkul","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2025032409590723700_r31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"N\u00e9meth","year":"2009","journal-title":"Nat. Med."},{"key":"2025032409590723700_r32","doi-asserted-by":"crossref","first-page":"F1050","DOI":"10.1152\/ajprenal.00461.2007","article-title":"Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury","volume":"294","author":"Yasuda","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2025032409590723700_r33","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/sj.ki.5000300","article-title":"Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects","volume":"69","author":"Yasuda","year":"2006","journal-title":"Kidney Int."},{"key":"2025032409590723700_r34","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4049\/jimmunol.1100350","article-title":"Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60","volume":"188","author":"Baranova","year":"2012","journal-title":"J. Immunol."},{"key":"2025032409590723700_r35","doi-asserted-by":"crossref","first-page":"F1116","DOI":"10.1152\/ajprenal.00366.2003","article-title":"A simplified method for HPLC determination of creatinine in mouse serum","volume":"286","author":"Yuen","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2025032409590723700_r36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1083\/jcb.200501113","article-title":"Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain","volume":"170","author":"Stuart","year":"2005","journal-title":"J. Cell Biol."},{"key":"2025032409590723700_r37","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1172\/JCI31539","article-title":"SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance","volume":"118","author":"Cai","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2025032409590723700_r38","doi-asserted-by":"crossref","first-page":"19826","DOI":"10.1074\/jbc.M109.020933","article-title":"Scavenger Receptor BI Protects against Septic Death through Its Role in Modulating Inflammatory Response","volume":"284","author":"Guo","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2025032409590723700_r39","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1194\/jlr.M700475-JLR200","article-title":"Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting","volume":"49","author":"Hoekstra","year":"2008","journal-title":"J. Lipid Res."},{"key":"2025032409590723700_r40","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1194\/jlr.M800410-JLR200","article-title":"Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production","volume":"50","author":"Hoekstra","year":"2009","journal-title":"J. Lipid Res."},{"key":"2025032409590723700_r41","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm1626","article-title":"Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype","volume":"13","author":"Podrez","year":"2007","journal-title":"Nat. Med."},{"key":"2025032409590723700_r42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/01.RES.0000176530.66400.48","article-title":"Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide","volume":"97","author":"Gupta","year":"2005","journal-title":"Circ. Res."},{"key":"2025032409590723700_r43","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1073\/pnas.90.24.12040","article-title":"In vivo protection against endotoxin by plasma high density lipoprotein","volume":"90","author":"Levine","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032409590723700_r44","doi-asserted-by":"crossref","first-page":"H866","DOI":"10.1152\/ajpheart.01232.2008","article-title":"Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats","volume":"297","author":"Zhang","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2025032409590723700_r45","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1172\/JCI39421","article-title":"Animal models of sepsis and sepsis-induced kidney injury","volume":"119","author":"Doi","year":"2009","journal-title":"J. Clin. Invest."},{"key":"2025032409590723700_r46","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/CCM.0b013e3181968f3a","article-title":"Effects of aging on the immunopathologic response to sepsis","volume":"37","author":"Turnbull","year":"2009","journal-title":"Crit. Care Med."},{"key":"2025032409590723700_r47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S0074-02762005000900038","article-title":"Failure of neutrophil migration toward infectious focus in severe sepsis: a critical event for the outcome of this syndrome","volume":"100","author":"Alves-Filho","year":"2005","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"2025032409590723700_r48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SHK.0b013e3181818466","article-title":"The role of neutrophils in severe sepsis","volume":"30","author":"Alves-Filho","year":"2008","journal-title":"Shock"},{"key":"2025032409590723700_r49","doi-asserted-by":"crossref","first-page":"31002","DOI":"10.1074\/jbc.M602794200","article-title":"Membrane sorting of toll-like receptor (TLR)-2\/6 and TLR2\/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting","volume":"281","author":"Triantafilou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2025032409590723700_r50","doi-asserted-by":"crossref","first-page":"8492","DOI":"10.1074\/jbc.M109.007526","article-title":"CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells","volume":"285","author":"Baranova","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2025032409590723700_r51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-pathol-011110-130327","article-title":"The pathogenesis of sepsis","volume":"6","author":"Stearns-Kurosawa","year":"2011","journal-title":"Annu. Rev. Pathol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/188\/6\/2749\/61631467\/1003445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/188\/6\/2749\/61631467\/1003445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T18:23:52Z","timestamp":1743099832000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/188\/6\/2749\/7981306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,3,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1003445","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,3]]},"published":{"date-parts":[[2012,3]]}}}